Abstract

More documents

Recommendations

Info

VISION Our vision is to become the leading publicly traded biotechnology company in the Central Eastern European region by 2010. We will achieve this through a combined growth and expansion strategy: • Membrane Transporter Assay Systems; • Personalized Medicine Diagnostics; • Novel Drug Development Platforms. HISTORY 1999: established in Szeged, Hungary. 2000: first capital was raised 2001: management team was set up 2001 through 2007: significant efforts in product development and international promotion of assay tools (membrane transporter products, screening services, licenses); development of a new MDR diagnostics product family (MDQ); global customer base, distribution and collaboration network established.
130 90 80 70 60 50 40 30 20 10 0 Number of Products & Services 72 80 52 59 12 17 18 26 3 6 8 80 33 45 56 18 2 4 7 115 95 2009 2009 2008 2008 Dynamic Growth - Comprehensive Pipeline Customer Base 140 120 100 80 60 40 20 0 2007 2000 2000 2001 2001 2002 2002 2003 2003 2004 2004 2005 2005 2006 2006 2007 2007 2008 2008 2009 2009 1999 1999 2000 2000 2001 2001 2002 2002 2003 2003 2004 2004 2005 2005 2006 2006 2007 Complex Solution Packages 1999 1999
Page 1 and 2: Biotechnology in Hungary and the Sz
Page 3 and 4: Life Sciences Have Traditionally Be
Page 5 and 6: … Producing Much From Scarce Reso
Page 7 and 8: In Central and Eastern Europe, , Hu
Page 9 and 10: What We Have... Highly skilled sci
Page 11 and 12: Strategic Goals of the Hungarian Bi
Page 13 and 14: ~20 Measures to Eliminate Major Bot
Page 18 and 19: Global Distribution Network KRISHGE
Page 20: Some of our references

Abstract

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?